Thomas Müntener

Thomas Müntener

Auto-generated profile, based on publicly available information

Thomas Müntener

Biozentrum, University of Basel, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2016 in The Journal of Physical Chemistry Letters
Verified
Journal Article
Closed access
TMThomas Müntener
Thomas Müntener
DHDaniel Häussinger
Daniel Häussinger
PSPhilipp Selenko
Philipp Selenko
FTFrancois-Xavier Theillet
Francois-Xavier Theillet

19 July 2024 in Science
Verified
Journal Article
Closed access
SBSamuel Berhanu
Samuel Berhanu
SMSagardip Majumder
Sagardip Majumder
TMThomas Müntener
Thomas Müntener
JWJames Whitehouse
James Whitehouse
CBCarolin Berner
Carolin Berner
AVAnastassia A. Vorobieva
Anastassia A. Vorobieva
Transmembrane β-barrels have considerable potential for a broad range of sensing applications. Current engineering approaches for nanopore sensors are limited to naturally occurring channels, which provide suboptimal starting points. By contrast, de novo protein design can in principle create an unlimited number of new nanopores with any desired properties. Here we describe a general approach to designing transmembrane β-barrel pores with different diameters and pore geometries. Nuclear magnetic resonance and crystallographic characterization show that the designs are stably folded with structures resembling those of the design models. The designs have distinct conductances that correlate with their pore diameter, ranging from 110 picosiemens (~0.5 nanometer pore diameter) to 430 picosiemens (~1.1 nanometer pore diameter). Our approach opens the door to the custom design of transmembrane nanopores for sensing and sequencing applications.

10 January 2022 in Chemical Reviews
Verified
Journal Article
Closed access
TMThomas Müntener
Thomas Müntener
DJDaniel Joss
Daniel Joss
DHDaniel Häussinger
Daniel Häussinger
SHSebastian Hiller
Sebastian Hiller

8 May 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
JPJoka Pipercevic
Joka Pipercevic
BKBastian Kohl
Bastian Kohl
RGRuta Gerasimaite
Ruta Gerasimaite
VCVéronique Comte-Miserez
Véronique Comte-Miserez
SHSarah Hostachy
Sarah Hostachy
SHSebastian Hiller
Sebastian Hiller
Many proteins involved in eukaryotic phosphate homeostasis are regulated by SPX domains. In yeast, the vacuolar transporter chaperone (VTC) complex contains two such domains, but mechanistic details of its regulation are not well understood. Here, we show at the atomic level how inositol pyrophosphates interact with SPX domains of subunits Vtc2 and Vtc3 to control the activity of the VTC complex. Vtc2 inhibits the catalytically active VTC subunit Vtc4 by homotypic SPX–SPX interactions via the conserved helix α1 and the previously undescribed helix α7. Binding of inositol pyrophosphates to Vtc2 abrogates this interaction, thus activating the VTC complex. Accordingly, VTC activation is also achieved by site-specific point mutations that disrupt the SPX–SPX interface. Structural data suggest that ligand binding induces reorientation of helix α1 and exposes the modifiable helix α7, which might facilitate its post-translational modification in vivo. The variable composition of these regions within the SPX domain family might contribute to the diversified SPX functions in eukaryotic phosphate homeostasis.

30 August 2018 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
TMThomas Müntener
Thomas Müntener
JKJérémy Kottelat
Jérémy Kottelat
AHAnnika Huber
Annika Huber
DHDaniel Häussinger
Daniel Häussinger

10 April 2019 in Chemical Science
Verified
Journal Article
Open access
PDF file
KZKaspar Zimmermann
Kaspar Zimmermann
DJDaniel Joss
Daniel Joss
TMThomas Müntener
Thomas Müntener
ENElisa S. Nogueira
Elisa S. Nogueira
MSMarc Schäfer
Marc Schäfer
DHDaniel Häussinger
Daniel Häussinger
Unraveling the native structure of protein–ligand complexes in solution enables rational drug design. We report here the use of 19F pseudocontact shift (PCS) NMR as a method to determine fluorine positions of high affinity ligands bound within the drug target human carbonic anhydrase II with high accuracy. Three different ligands were localized within the protein by analysis of the obtained PCS from simple one-dimensional 19F spectra with an accuracy of up to 0.8 Å. In order to validate the PCS, four to five independent magnetic susceptibility tensors induced by lanthanide chelating tags bound site-specifically to single cysteine mutants were refined. Least-squares minimization and a Monte–Carlo approach allowed the assessment of experimental errors on the intersection of the corresponding four to five PCS isosurfaces. By defining an angle score that reflects the relative isosurface orientation for different tensor combinations, it was established that the ligand can be localized accurately using only three tensors, if the isosurfaces are close to orthogonal. For two out of three ligands, the determined position closely matched the X-ray coordinates. Our results for the third ligand suggest, in accordance with previously reported ab initio calculations, a rotated position for the difluorophenyl substituent, enabling a favorable interaction with Phe-131. The lanthanide–fluorine distance varied between 22 and 38 Å and induced 19F PCS ranged from 0.078 to 0.409 ppm, averaging to 0.213 ppm. Accordingly, even longer metal–fluorine distances will lead to meaningful PCS, rendering the investigation of protein–ligand complexes significantly larger than 30 kDa feasible.